CTS CTS CORP Insider Trading

CTS CEO O'Sullivan sells 130,000 shares for $8,484,804.95 via 10b5-1 plan; retains 307,693 shares

Kieran M O'Sullivan, who was CEO at the time, executed 3 separate sales totaling 130,000 shares for $8,484,804.95 across 2026-06-01 to 2026-06-03 at prices ranging from $63.31 to $66.67. This transaction is part of a pre-arranged 10b5-1 trading plan adopted on 2026-03-02, making it scheduled rather than discretionary. The sales reduced his holdings by 29.7%, from 437,693 shares to 307,693 shares post-transaction. His prior trades at CTS over five separate dates in December 2024 saw 30-day declines ranging from -3.7% to -7.7% and 90-day declines ranging from -20.6% to -23.6%, establishing a historical context of sales preceding stock weakness at this specific ticker. The stock currently trades at $67.04, within 0.1% of its 52-week high of $66.99, and has risen 18.6% over 30 days and 31.0% over 90 days.

CTS CFO Ashish Agrawal sold 25,000 shares at $53.00 on 2026-02-02; now holds 105,987 shares (-19.1% reduction).

Agrawal sold 25,000 shares valued at $1,325,000.00 at a price very close to the current 52-week high of $53.28, reducing his holdings by -19.1%. His cross-ticker track record shows 1 prior sell with a 90-day well-timed rate of 0.00%, indicating his past sales have not preceded stock declines. At this specific ticker (CTS), the prior sale on 2024-02-06 was followed by a +5.8% 90-day return, meaning the stock rose after he sold. The company faces headwinds with annual revenue declining -6.3% year-over-year and a relatively elevated P/E of 26.12, though this single sale alone does not signal a broader strategic shift given his continued large remaining position of 105,987 shares.

CTS CEO O'Sullivan sells 15.2K shares in 2 transactions for $836.4K, retaining 375.6K post-sale

Kieran M O'Sullivan, President & CEO of CTS Corp, executed 2 separate sales on 2024-12-06 and 2024-12-09, selling 8,494 shares at $54.50 and 6,690 shares at $55.83, totaling 15,184 shares for $836,385.91 at a blended average price of $55.08. The sale represents a 3.9% reduction in holdings, leaving the CEO with 375,643 shares. The transactions were executed near the top of the 52-week range ($39.91–$58.97), with current price at $56.23 and the stock up 22.7% over 90 days. Cross-ticker, O'Sullivan's prior 8 sells averaged +9.0% over 30 days and +7.3% over 90 days with a 0.00% well-timed rate, indicating his recent sales have not preceded stock declines. At CTS specifically, his most recent measurable sale (2024-05-01) returned +1.6% over 90 days. The CEO maintains substantial holdings worth approximately $21.1M at current market price, consistent with long-term stewardship positioning.

CTS CEO O'Sullivan sells 22,423 shares for $1.2M at $55.11 blended average; stock near 52-week high

Kieran M O'Sullivan, President & CEO of CTS Corp, executed 2 separate sales on 2024-12-04 and 2024-12-05 totaling 22,423 shares for $1,235,798.34 ($1.2M) at a blended average price of $55.11, reducing his holdings from 413,250 shares to 390,827 shares (-5.4%). The transaction occurred when CTS stock was trading near its 52-week high of $58.97 (current price $54.81 is -7.0% from the 52-week high). The insider's cross-ticker track record shows 7 prior open-market sales with an average 90-day return of +7.3% and a well-timed rate of 0.00%, indicating prior sales have been poorly timed relative to subsequent price appreciation. At the CTS ticker specifically, his 2 most recent measurable prior sales (2024-04-30 and 2024-05-01) both generated positive 90-day returns of +13.7% and +1.6%, respectively, suggesting sub-optimal exit timing. The sale occurs against a backdrop of -6.2% annual revenue growth and elevated valuation (P/E 27.54), but without a scheduled trading plan flag, the sale's timing relative to these fundamentals cannot be inferred.

CTS CEO Kieran O'Sullivan sold 42,393 shares at blended avg $55.76; post-sale holding 413,250 shares

Kieran O'Sullivan, President & CEO of CTS Corp, executed 2 separate open-market sales on consecutive days (December 2–3, 2024), totaling 42,393 shares for $2,363,651.11 at a blended average price of $55.76. His post-transaction holdings of 413,250 shares represent a -9.3% reduction from 455,643 shares pre-transaction. At his same ticker, O'Sullivan's prior 4 measurable sales showed average 90-day returns of +7.6%, with 0 of 4 well-timed at the 90-day mark (meaning the stock typically rose after his prior sells, not fell). The stock is currently -5.9% from its 52-week high of $58.97 and has gained 7.7% over 30 days and 20.2% over 90 days, reflecting recent upward momentum. Fundamentals show annual revenue growth of -6.2% year-over-year and a P/E of 27.89. The sale occurred while the stock was in the upper quartile of its 52-week range, though after a 20% gain over three months.